Skip to main content
COCH
NASDAQ Life Sciences

首批患者在Envoy Medical的完全植入式听觉植入器临床试验中达到12个月的终点

feedReported by TMX Newsfile
Sentiment info
Positive
Importance info
8
Price
$0.687
Mkt Cap
$51.134M
52W Low
$0.363
52W High
$1.91
Market data snapshot near publication time

summarizeSummary

Envoy Medical宣布，其完全植入式Acclaim听觉植入器的临床试验中，首批三名患者已成功完成12个月的终点访问。这是一个重要的里程碑，因为试验的主要终点与12个月的数据有关，其实现使公司按照计划提交FDA的上市前批准（PMA）。这一积极的发展为这家微型上市公司提供了急需的提振，该公司最近披露了继续经营警告、高度稀释性的发行、纳斯达克退市威胁和审计师变更。试验的成功完成和随后的FDA批准对于公司的长期可行性和商业化努力至关重要。

在该公告发布时，COCH的交易价格为$0.69，交易所为NASDAQ，所属行业为Life Sciences，市值约为$5113.4万。 52周交易区间为$0.36至$1.91。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：TMX Newsfile。

show_chartPrice Chart

Share this article

Copied!

feed COCH - Latest Insights

COCH
Apr 21, 2026, 4:25 PM EDT
Filing Type: 8-K
Importance Score:
7
Envoy Medical Appoints Experienced Medical Device Executive Charles McKhann to Board
Sentiment: Positive
View Wiseek Article
COCH
Apr 02, 2026, 4:01 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Envoy Medical Finalizes Proxy for Shareholder Vote on Highly Dilutive Warrant Issuance and Equity Plans
Sentiment: Negative
View Wiseek Article
COCH
Apr 01, 2026, 8:00 AM EDT
Source: TMX Newsfile
Importance Score:
8
First Patients Reach 12-Month Endpoint in Pivotal Trial for Envoy Medical's Fully Implanted Cochlear Implant
Sentiment: Positive
View Wiseek Article
COCH
Mar 31, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Envoy Medical Changes Auditor to EisnerAmper Amidst Going Concern Warning
Sentiment: Neutral
View Wiseek Article
COCH
Mar 27, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Envoy Medical Reports Key Clinical Trial Progress, $32M Debt Extinguishment, and $30M Capital Raise
Sentiment: Positive
View Wiseek Article
COCH
Mar 23, 2026, 4:31 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Envoy Medical Seeks Shareholder Approval for Massive Dilution from Recent Offering Warrants and New Equity Plans
Sentiment: Negative
View Wiseek Article
COCH
Mar 23, 2026, 9:26 AM EDT
Filing Type: 10-K
Importance Score:
8
Envoy Medical Faces Going Concern Warning Amidst Deeply Discounted $30M Offering and Nasdaq Delisting Threat; Insiders Show Conviction with $8.17M Buys
Sentiment: Negative
View Wiseek Article
COCH
Feb 27, 2026, 9:11 AM EST
Filing Type: 8-K
Importance Score:
8
Envoy Medical Regains Nasdaq Compliance, Averting Delisting Threat
Sentiment: Positive
View Wiseek Article
COCH
Feb 17, 2026, 4:51 PM EST
Filing Type: 4
Importance Score:
7
Director Mona Chetan Patel Buys $125K in Envoy Medical Stock and Warrants
Sentiment: Positive
View Wiseek Article
COCH
Feb 17, 2026, 4:49 PM EST
Filing Type: 4
Importance Score:
7
Envoy Medical Interim CFO Purchases $85,000 in Stock and Warrants Following Recent Public Offering
Sentiment: Positive
View Wiseek Article